SYNB - Putnam BioRevolution ETF ETF Analysis | Stock Taper
Logo

SYNB

Putnam BioRevolution ETF
Putnam BioRevolution ETF Franklin Templeton
$31.61 -0.37% (-0.12)

Managing Company Franklin Templeton
Asset Under Management $1.58M
Inception Date Sep 29, 2022
Expense Ratio 0.70%
52w High $31.73
52w Low $24.57
Volume 449
Avg Volume 850
Asset Class Equity

About Putnam BioRevolution ETF

The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on "biology revolution" companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors....

SECTOR HOLDINGS

Healthcare Healthcare
61.86%
Basic Materials Basic Materials
21.46%
Technology Technology
9.36%
Consumer Defensive Consumer Defensive
5.83%
Consumer Cyclical Consumer Cyclical
1.49%

ASSET ALLOCATION BY REGION

Other
100.00%

Holdings (Top 20)

No holdings data available.